We advertise our grants annually in the scientific journal 'Nature'. In 2008 the grant round will open in June.
Anyone interested in applying for a CGD research grant has to first complete a preliminary application. Preliminary applications are reviewed by members of our medical panel and three lay reviewers from our Trustee board who rate the applications according to relevance to the charity’s research strategy and whether the science is likely to lead to benefit for the CGD community. At this stage approximately 30-50% of the applications are rejected.
Successful applicants are then asked to submit a full application. Three external independent experts with related research experience reviews each application. These peer reviewers score the applications on the basis of quality, relevance, originality, feasibility and value for money. The Trust’s Medical and Scientific Advisory Panel consider their recommendations. This panel of experts advises the Trust on the best quality research to fund and on setting priorities for future CGD research.
The Association of Medical Research Charities approves all our peer review methods and in 2006 the CGD Research Trust received a certificate of best practice for its peer review procedures.
Our Medical and Scientific Advisory Panel
The Panel meets each year to discuss grant applications. The Panel considers reports from external referees and advises the Trustees on the projects of greatest merit. We are extremely fortunate and pleased to have on our panel:
- Professor Eric Alton , Professor of Gene Therapy and Respiratory Medicine, Imperial College London.
- Professor David W. Denning , Professor of Medicine and Medical Mycology, Wythenshawe Hospital, Manchester.
- Professor Terrence Hamblin , Professor of Immunohaematology, University of Southampton. Honorary Consultant Haematologist, Southampton University Hospitals, Royal Bournemouth Hospital and Kings College Hospital, London.
- Dr Mansel Haeney , Consultant Immunologist, Hope Hospital, Salford.
- Professor Sue Kingsman , Professor of Molecular Genetics and Fellow of Trinity College, Oxford. Research Director at Oxford BioMedica plc.
- Professor Stella Knight , Northwick Park Institute of Medical Research.
- Dr Majlinda Lako , Institute of Human Genetics, International Centre for Life, Newcastle upon Tyne.
- Dr Terry Rabbits , Head of Protein and Nucleic Acid Chemistry Division, MRC Laboratory of Molecular Biology, Cambridge.
- Professor Reinhard Segar , Consultant paediatrician, Children’s Hospital, Zurich.
- Professor Len Seymour, Professor of Genetic Therapies, President of the British Society for Gene Therapy, University of Oxford
- Dr Suzanne Watt , National Scientific Head of the National Blood Service Stem Cell and Immuno-therapy Section, John Radcliffe Hospital, Oxford.
IMPORTANT NOTE :
The information contained on this website is intended only as a guideline, not as a substitute for medical advice. Always consult your doctor if you or your child has any CGD symptoms or concerns.
© 2001-2005 The Chronic Granulomatous Disorder (CGD) Research Trust
Registered Charity No. 1003425 email:cgd@cgdrt.co.uk
The CGD Research Trust is a member of the Association of Medical Research Charities (AMRC), the Genetic Interest Group (GiG) and an associate member of the International Patient Organisation of Primary Immunodeficiencies (IPOPI)
Terms and Conditions | Privacy
